June 1, 2026 · Form 4 insider transaction
Peetz Christopher sold 16,595 shares of Mirum Pharmaceuticals, Inc. at $95.34 per share, a transaction worth $1.58M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $95.34, and the range of prices were between $94.91 and $95.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.